Merck & Co Inc

MRKNYSE · USD
148.08USD0.00 (-1.88%)
5810

Merck & Co Inc (MRK) Implied Volatility Current

MRK implied volatility is 29%. IV Rank is 46%, placing current premiums in the middle of their 52-week range.

Read more

Tracking MRK implied volatility helps you identify when options premiums on Merck & Co Inc are historically cheap or expensive, and where the best trades are hiding. Merck & Co Inc implied volatility reflects the market's expectation of future price movement: when MRK IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Merck & Co Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For MRK, tracking metrics like MRK IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on MRK signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products.

It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where MRK implied volatility sits today versus where it has been. Our scanner ranks Merck & Co Inc implied volatility against its historical range, surfaces extremes in MRK IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Merck & Co Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
45.83%IV Rank
Moderate

IV is below its typical range - premiums look reasonable for buyers.

Implied Volatility (30d)28.84%

IV Rank45.83%

Historical Volatility (30d)41.84%

IV - HV-13.00%

As of September 23, 2026

Trade options with IV on your side

Track MRK IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial